T3	eligibility 372 417	premenopausal women at risk for breast cancer
T4	total-participants 469 472	235
T8	control 597 604	placebo
T16	outcome-Measure 1158 1170	IGF-I levels
T17	outcome 1408 1428	optic nerve ischemia
T18	outcome 1437 1459	deep venous thrombosis
T20	outcome 1613 1627	breast cancers
T7	outcome 987 999	IGF-I levels
T1	intervention 89 123	low-dose tamoxifen and fenretinide
T2	outcome 1510 1529	menopausal symptoms
T5	outcome 1531 1552	endometrial thickness
T6	outcome 1554 1560	polyps
T9	outcome 1565 1578	ovarian cysts
T10	outcome 1242 1253	dropped out
T11	outcome 1282 1296	adverse events
T12	outcome 1316 1329	other reasons
T13	iv-bin-abs 1331 1334	One
T14	iv-bin-abs 1404 1407	one
T15	iv-bin-abs 1433 1436	one
